Table 2.
1H-MRS metabolite estimates at baseline and 12 weeks for the three groups.
| Responders | Nonresponders | HC | |
|---|---|---|---|
| pACC | |||
| Baseline | |||
| Sample size | 27 | 14 | 41 |
| Glutamate | 15.54 ± 3.71 | 19.15 ± 5.80 | 16.56 ± 4.15 |
| Glx | 19.84 ± 4.35 | 23.73 ± 8.43 | 21.40 ± 6.13 |
| 12 weeks | |||
| Sample size | 23 | 10 | ___ |
| Glutamate | 15.54 ± 2.53 | 16.25 ± 3.59 | ___ |
| Glx | 18.81 ± 3.23 | 21.64 ± 3.58 | ___ |
| dACC | |||
| Baseline | |||
| Sample size | 27 | 15 | 41 |
| Glutamate | 12.82 ± 2.81 | 14.45 ± 2.42 | 13.53 ± 1.85 |
| Glx | 15.61 ± 3.27 | 17.88 ± 2.96 | 16.54 ± 2.36 |
| 12 weeks | |||
| Sample size | 23 | 11 | ___ |
| Glutamate | 12.31 ± 1.33 | 12.81 ± 1.91 | ___ |
| Glx | 15.03 ± 1.87 | 15.39 ± 2.68 | ___ |
Data are presented as mean ± standard deviation. pACC: anterior cingulate cortex at ventral and perigenual voxel; dACC: dorsal anterior cingulate cortex; Glx: glutamate + glutamine. The unit of neurometabolite measurements is mM.